BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22686456)

  • 1. Increased length of stay and costs associated with inpatient management of vascular access failures.
    Sawant A; Mills PK; Dhingra H
    Semin Dial; 2013; 26(1):106-10. PubMed ID: 22686456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis access cost comparisons among incident tunneled catheter patients.
    Wagner JK; Fish L; Weisbord SD; Yuo TH
    J Vasc Access; 2020 May; 21(3):308-313. PubMed ID: 31495265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of diabetes mellitus on costs and length of stay in patients with peripheral arterial disease undergoing vascular surgery.
    Malone M; Lau NS; White J; Novak A; Xuan W; Iliopoulos J; Crozier J; Dickson HG
    Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):447-51. PubMed ID: 25116276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned creation of vascular access saves medical expenses for incident dialysis patients.
    Wu LC; Lin MY; Hsieh CC; Chiu HC; Mau LW; Chiu YW; Chen HC; Hwang SJ
    Kaohsiung J Med Sci; 2009 Oct; 25(10):521-9. PubMed ID: 19767257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management and outcome of occluded haemodialysis access: a retrospective audit.
    Yehia M; McDonald M; Walker R
    N Z Med J; 2002 Nov; 115(1166):U258. PubMed ID: 12552276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis.
    Manns B; Tonelli M; Yilmaz S; Lee H; Laupland K; Klarenbach S; Radkevich V; Murphy B
    J Am Soc Nephrol; 2005 Jan; 16(1):201-9. PubMed ID: 15563567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
    Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
    Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis Vascular Access: Rising Costs as a Surrogate Marker for Patency and Function of Arteriovenous Fistulas.
    Feldman ZM; Liu LB; Abramowitz SD; Faries PL; Marin ML; Schanzer HR; Teodorescu VJ
    Ann Vasc Surg; 2017 Jan; 38():136-143. PubMed ID: 27546853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining Hemodialysis Reliable Outflow catheter performance and cost in hemodialysis access.
    Torrent DJ; Maness MR; Kachare SD; Zink JN; Haisch CE; Harland RC; Morgan C; Guyton RL; Colomb AG; Barham DW; Katz EC; Stoner MC
    J Surg Res; 2014 Nov; 192(1):1-5. PubMed ID: 25151468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
    Schon D; Blume SW; Niebauer K; Hollenbeak CS; de Lissovoy G
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy.
    Brophy DF; Daniel G; Gitlin M; Mayne TJ
    Ann Pharmacother; 2010 Jan; 44(1):43-9. PubMed ID: 20028955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of intensive care unit resource use and its estimated cost in Medicare.
    Milbrandt EB; Kersten A; Rahim MT; Dremsizov TT; Clermont G; Cooper LM; Angus DC; Linde-Zwirble WT
    Crit Care Med; 2008 Sep; 36(9):2504-10. PubMed ID: 18679127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure.
    Brenner L; Singh AK; Campbell D; Frei F; Winkelmayer WC
    Clin J Am Soc Nephrol; 2006 May; 1(3):455-61. PubMed ID: 17699245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of the use of stent grafts to salvage failed arteriovenous accesses.
    Webb KM; Cull DL; Carsten CG; Johnson BL; Taylor SM
    Ann Vasc Surg; 2010 Jan; 24(1):34-8. PubMed ID: 19765947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First hemodialysis access selection varies with patient acuity.
    Friedman AL; Walworth C; Meehan C; Wander H; Shemin D; DeSoi W; Kitsen J; Hill C; Lambert C; Mesler D
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S4-10. PubMed ID: 11053581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
    Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
    J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic value of performing dialysis vascular access procedures in a freestanding office-based center as compared with the hospital outpatient department among Medicare ESRD beneficiaries.
    Dobson A; El-Gamil AM; Shimer MT; DaVanzo JE; Urbanes AQ; Beathard GA; Litchfield TF
    Semin Dial; 2013; 26(5):624-32. PubMed ID: 24033719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients characteristics and outcome of 518 arteriovenous fistulas for hemodialysis in a sub-Saharan African setting.
    Fokou M; Ashuntantang G; Teyang A; Kaze F; Chichom Mefire A; Halle MP; Angwafo F; Takongmo S; Sandmann W
    Ann Vasc Surg; 2012 Jul; 26(5):674-9. PubMed ID: 22284777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.